| Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q2 24 | 09/04 17:48 | newsfilecorp.com |
| Bio-Path Holdings to Present at H.C. Wainwright 26th Annual Global Investment Conference | 09/03 07:00 | globenewswire.com |
| Bio-Path Holdings Reports Second Quarter 2024 Financial Results | 08/15 07:00 | globenewswire.com |
| Bio-Path Holdings to Announce Second Quarter 2024 Financial Results on August 15, 2024 | 08/08 07:00 | globenewswire.com |
| Bio-Path Holdings Provides Clinical Update and Expansion Plans | 07/08 07:00 | globenewswire.com |
| Why Is Bio-Path (BPTH) Stock Up 20% Today? | 06/14 11:30 | investorplace.com |
| Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at European Hematology Association Congress | 06/14 07:00 | globenewswire.com |
| Bio-Path Holdings Announces Closing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules | 06/05 17:46 | globenewswire.com |
| Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q1 24 | 06/04 16:55 | newsfilecorp.com |